|[September 11, 2013]
Global Green, Inc. Poultry Vaccine for Salmonella to Offer Chemical-Free Solution
TALLAHASSEE, Fla. --(Business Wire)--
Green, Inc. (OTCBB:GOGC) cites an article in last month's Washington
Post that the U.S. Department of Agriculture (USDA) is reviewing
research revealing that new bacteria-killing chemicals used in chicken
industry processing plants may be masking the presence of salmonella and
other pathogens that remain on the birds that consumers buy, causing
Global Green has developed a patented vaccine to reduce Salmonella in
chicken farming, Salmogenics.
It is a safe vaccine that could have significant global impact against
this dreaded infectious disease, without dangerous side effects.
Salmogenics is currently in the final stage of the USDA approval process.
On September 4, the Company announced the signing of an agreement with Merial
Ltd., the Animal Health Division of Sanofi,
to conduct an internal evaluation of Global Green's patented Salmogenics
vaccine technology. At the conclusion of the evaluation, Merial
has the first option to enter into a license agreement with Global Green
for the manufacture, distribution, and sale of the vaccine.
The chemical issue that reportedly currently exists in chicken industry
processing plants came to the department's attention this spring after
chemical companies pointed to academic research that shows there could
be a problem with chicken farming and told the USDA that further study
Some experts say the rising tide of chemicals may be causing
unanticipated side effects and endangering food safety. Some USDA
inspectors believe such chemicals can contribute to a host of healthcare
and medical problems, including respiratory ailments and persistent skin
The World Health Organization (WHO) reports that Salmonellosis is one of
the most common and widely distributed infectious diseases, affecting
the healthcare of tens of millions of people every year. This is a
global health issue.
Mehran Ghazvini, DC, NMD, Chairman and CEO of biotech company Global
Green, Inc., stated "As an infectious disease, Salmonellosis is
responsible for a significant burden of disease in the global health
arena and is notoriously difficult to control in the poultry
farm-to-market cycle. When Salmogenics is used, salmonella contamination
is reduced. Not only will consumers have access to a healthier protein
source, but the amount of chemicals used in the processing plant will be
reduced, providing a healthier work environment for those who work
there. This will promote food safety and animal health."
About Global Green, Inc.
Green, Inc. is a green bio-pharmaceutical company committed to
identifying technology platforms and commercializing vaccines that
contain natural organisms that are not genetically modified, utilizing
pharmaceutical standards without the use of mercury. For more
information, visit www.globalgreeninc.com.
This press release may contain certain forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
Investors are cautioned that such forward-looking statements involve
risks and uncertainties which include, among others, the inherent
uncertainties associated with smaller reporting companies including,
without limitation, other risks detailed from time to time in the
Company's periodic reports filed with the Securities and Exchange
[ Back To Technology News's Homepage ]